Amplatzer PFO

FIRST TO MARKET
STILL FIRST WORLDWIDE

Industry-Leading PFO Solution

The first occluder developed specifically for patent foramen ovale (PFO) closure continues to leverage its role in the industry, with data conclusively demonstrating the excellent safety profile of the Amplatzer PFO Occluder.1

The Amplatzer PFO Occluder’s design features are responsible for its success.

  • DURABLE NITINOL WIRE MESH WITH POLYESTHER FABRIC THREAD

    Excellent visibility under flouoro

  • ASYMMETRIC DOUBLE DISC DESIGN

    Minimizes material in the left atrium*

  • INTAGLIO WIRE TREATMENT

    Designed to reduce nickel leaching2

Avoiding Complexity in Closure

Implanting the Amplatzer PFO Occluder is easy and straightforward, with no need for a lengthy learning curve for successful insertion.

Unique Self-Expanding Discs

Linked by a short-connecting waist, the discs align to the PFO with no need for an additional “locking” step

Low-Profile Delivery

8F & 9F introducer sheaths for multiple sizes (18, 25, 30, 35 mm) enable treatment of patients with smaller vasculature

Fully Recapturable, Repositional

This allows for confirmation of proper placement prior to final release of the device

Engineered to Fit Anatomical Differences

There are multiple device sizes to address cardiovascular structural differences. In addition, the flexible, narrow waist of the device ensures that each disc is well apposed to the septal wall.

AP2947037-WBO Rev. A

References

* On the most commonly used sizes (25 mm and 35 mm devices)

  1. Saver JL, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke.N Engl J Med. 2017; 377:1022-1032. doi: 10.1056/NEJMoa1610057.
  2. Based on internal lab testing. Data on file at Abbott.
     

This site uses cookies to improve your experience.

To find out more please read our Privacy and Cookies policy.

Ok

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.